BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27974250)

  • 21. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis.
    Djilali-Saiah I; Fakhfakh A; Louafi H; Caillat-Zucman S; Debray D; Alvarez F
    J Hepatol; 2006 Dec; 45(6):844-50. PubMed ID: 17050030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune hepatitis in a murine autoimmune polyendocrine syndrome type 1 model is directed against multiple autoantigens.
    Hardtke-Wolenski M; Taubert R; Noyan F; Sievers M; Dywicki J; Schlue J; Falk CS; Ardesjö Lundgren B; Scott HS; Pich A; Anderson MS; Manns MP; Jaeckel E
    Hepatology; 2015 Apr; 61(4):1295-305. PubMed ID: 25475693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis.
    Yüksel M; Laukens D; Heindryckx F; Van Vlierberghe H; Geerts A; Wong FS; Wen L; Colle I
    Int J Exp Pathol; 2014 Oct; 95(5):309-20. PubMed ID: 25112417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibodies and physiopathogeny of autoimmune hepatitis].
    García-Leiva J; Ríos-Vaca A; Torre-Delgadillo A
    Rev Invest Clin; 2003; 55(5):577-82. PubMed ID: 14968479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Autoimmune hepatitis and overlap syndrome: diagnosis].
    Berg PA; Klein R
    Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the antigenicity of the formiminotransferase-cyclodeaminase in type 2 autoimmune hepatitis.
    Renous R; Lapierre P; Djilali-Saiah I; Vitozzi S; Alvarez F
    Exp Cell Res; 2004 Jan; 292(2):332-41. PubMed ID: 14697341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune hepatitis: evolving concepts.
    Diamantis I; Boumpas DT
    Autoimmun Rev; 2004 Mar; 3(3):207-14. PubMed ID: 15110233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aetiopathogenesis of autoimmune hepatitis.
    Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
    J Autoimmun; 2010 Feb; 34(1):7-14. PubMed ID: 19766456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic T Cell Tolerance Induction in An Inflammatory Environment.
    Dywicki J; Noyan F; Misslitz AC; Hapke M; Galla M; Schlue J; Liblau RS; Taubert R; Manns MP; Jaeckel E; Hardtke-Wolenski M
    Dig Dis; 2018; 36(2):156-166. PubMed ID: 29020680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a New Murine Model of Type 2 Autoimmune Hepatitis Using a Human Liver Protein.
    Thomas-Dupont P; Grube-Pagola P; Izaguirre-Hernández IY; Hernández-Flores KG; Sánchez-Marce EE; Cano-Contreras AD; Remes-Troche JM; Vivanco-Cid H
    Am J Pathol; 2022 Jan; 192(1):21-30. PubMed ID: 34717895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay.
    Miyakawa H; Kawashima Y; Kitazawa E; Kawaguchi N; Kato T; Kikuchi K; Imai E; Fujikawa H; Hashimoto E; Schlumberger W
    J Autoimmun; 2003 Aug; 21(1):77-82. PubMed ID: 12892738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibodies and autoantigens in autoimmune hepatitis.
    Strassburg CP; Manns MP
    Semin Liver Dis; 2002 Nov; 22(4):339-52. PubMed ID: 12447706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies and their antigens in autoimmune hepatitis.
    Bogdanos DP; Mieli-Vergani G; Vergani D
    Semin Liver Dis; 2009 Aug; 29(3):241-53. PubMed ID: 19675997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Requirements and challenges of a preclinical autoimmune hepatitis mouse model.
    Hardtke-Wolenski M; Noyan F; Jaeckel E
    Dig Dis; 2011; 29(4):402-10. PubMed ID: 21894011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis].
    Bakker-Jonges LE; ter Borg PC; van Buuren HR; Hooijkaas H
    Ned Tijdschr Geneeskd; 2006 Mar; 150(9):490-4. PubMed ID: 16553048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.
    Holdener M; Hintermann E; Bayer M; Rhode A; Rodrigo E; Hintereder G; Johnson EF; Gonzalez FJ; Pfeilschifter J; Manns MP; Herrath Mv; Christen U
    J Exp Med; 2008 Jun; 205(6):1409-22. PubMed ID: 18474629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review.
    Kerkar N; Yanni G
    J Autoimmun; 2016 Jan; 66():17-24. PubMed ID: 26377632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance.
    Lapierre P; Béland K; Yang R; Alvarez F
    Hepatology; 2013 Jan; 57(1):217-27. PubMed ID: 22911361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis.
    Mix H; Weiler-Normann C; Thimme R; Ahlenstiel G; Shin EC; Herkel J; David CS; Lohse AW; Rehermann B
    Gastroenterology; 2008 Dec; 135(6):2107-18. PubMed ID: 18773898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of autoimmune hepatitis.
    Vergani D; Mieli-Vergani G
    Pediatr Transplant; 2004 Dec; 8(6):589-93. PubMed ID: 15598331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.